- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07468019
Organization's Unique Protocol ID
Adaptation and Patient Satisfaction of 3-D Printed Versus Conventional Acrylic Overdentures in Patients With Ectodermal Dysplasia: A Crossover Prospective Clinical Trial
Ectodermal dysplasia is a rare inherited condition that affects structures derived from the ectoderm, including teeth, skin, hair, and sweat glands. Dental findings are often severe and include missing or malformed teeth and poorly developed jaw ridges. These abnormalities can significantly affect chewing, speech, facial appearance, and quality of life, especially in children and young adults. Removable dentures, particularly overdentures when some teeth are present, are commonly used to restore function and appearance in these patients because they are conservative and cost-effective. However, conventional acrylic dentures may show dimensional changes during processing, which can lead to poor denture fit, reduced retention, and lower patient satisfaction. Three-dimensional (3-D) printed dentures are a newer digital fabrication method that may reduce material shrinkage and improve denture adaptation. Despite these potential advantages, clinical evidence comparing 3-D printed and conventional overdentures in patients with ectodermal dysplasia remains limited, highlighting the need for well-designed clinical studies.
The purpose of this study is to compare patient satisfaction and denture base adaptation between 3-D printed maxillary overdentures and conventional acrylic maxillary overdentures in patients with ectodermal dysplasia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yasmine Hisham Mohsen
- Phone Number: +201007771412
- Email: yasmine.hisham@dentistry.cu.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Faculty of Dentistry, Cairo University
-
Contact:
- Nouran M Abd ElNabi, Professor
- Phone Number: +201001539310
- Email: Nouranabdelnabi@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age must range from 10-35 years.
- Must have a few remaining teeth in the maxilla.
- Must will to attend all follow-ups.
Exclusion Criteria:
- Extreme anatomical limitations such as a large torus that requires surgical excision.
- Allergy to dentures made of resins.
Pathological changes of residual ridges as recurrent or persistent ulcers, osteomyelitis and infections.
4. Patients with medical or psychological conditions as physical disability or mental retardation that hinder cooperation in the follow up visits and answering the questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital 3-D printed overdentures
|
Overdenture is constructed using 3 -D printing technology not conventional processing of acrylic resin
|
|
Active Comparator: conventional acrylic overdenture
|
overdentures will be constructed using Conventional acrylic processing method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction
Time Frame: after 1 week and after 3 months after delivery of each denture
|
Patient satisfaction will be measured using patient satisfaction questionnaire in ordinal scale.
It uses a 5- point Likert scale to give a removable denture satisfaction index.
|
after 1 week and after 3 months after delivery of each denture
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Denture adaptation
Time Frame: on delivery day and after 3 months of each denture delivery
|
Denture adaptation will be measured using surface matching software in deviation values.
Unit is µm.
|
on delivery day and after 3 months of each denture delivery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ED-OD-3DPvsCA-CO-CT-2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ectodermal Dysplasia
-
Edimer PharmaceuticalsCompletedX-linked Hypohidrotic Ectodermal DysplasiaUnited States
-
Edimer PharmaceuticalsActive, not recruitingX-linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
-
University Hospital ErlangenEdimer PharmaceuticalsCompletedX-linked Hypohidrotic Ectodermal DysplasiaGermany
-
EspeRare FoundationIQVIA Pty Ltd; Pierre Fabre MedicamentRecruitingX-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)United States, Spain, France, Germany, Italy, United Kingdom
-
Edimer PharmaceuticalsCompletedX-linked Hypohidrotic Ectodermal Dysplasia | Hypohidrotic Ectodermal DysplasiaUnited States
-
Edimer PharmaceuticalsCompletedX-linked Hypohidrotic Ectodermal Dysplasia | Hypohidrotic Ectodermal DysplasiaSpain
-
Pierre Fabre MedicamentActive, not recruitingX-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)France, Germany
-
Edimer PharmaceuticalsCompletedX-Linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
-
Edimer PharmaceuticalsCompletedX Linked Hypohidrotic Ectodermal DysplasiaUnited States
-
Edimer PharmaceuticalsCompletedX-Linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
Clinical Trials on 3-D printed overdenture
-
October University for Modern Sciences and ArtsCompleted
-
Boston Children's HospitalFitz Frames, Inc.Not yet recruitingRefractive Errors | Myopia | Hyperopia | Amblyopia
-
Tanta UniversityCompletedMaxillofacial Prosthesis UserEgypt
-
Barts & The London NHS TrustInnovate UK; AndiamoCompletedCerebral Palsy | Ankle Foot Orthosis (AFO)United Kingdom
-
Damascus UniversityCompletedEndodontic Disease | Endodontic Re-treatment FailureSyrian Arab Republic
-
October University for Modern Sciences and ArtsCompleted
-
Sherif Aly SadekCairo UniversityRecruiting
-
National Dental Centre, SingaporeNational Medical Research Council (NMRC), SingaporeRecruitingPartial-edentulismSingapore
-
Riphah International UniversityCompletedLow Back Pain | Exercise | Lordosis | LumbarPakistan